Why the study?
Data indicate protective effects of beta-blockers in critically ill patients, but scientific society consensus and guidelines on their use have been lacking.
Population
Critically ill adult patients
Design
Expert consensus statement using modified Delphi and RAND-UCLA methods
Authors
Loading...
First guideline on β-blockers in critically ill; supports bedside decisions while directing needed RCTs.
This SIAARTI expert consensus statement provides guidance on using beta-blockers to manage persistent tachycardia in critically ill patients, emphasizing the need to first rule out and address secondary causes like hypovolemia.
Guarracino et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: